Small Molecule Angiotensin II Type 2 Receptor (AT2R) Antagonists as Novel Analgesics for Neuropathic Pain: Comparative Pharmacokinetics, Radioligand Binding, and Efficacy in Rats-Reference-Cited by-同舟云学术

Small Molecule Angiotensin II Type 2 Receptor (AT2R) Antagonists as Novel Analgesics for Neuropathic Pain: Comparative Pharmacokinetics, Radioligand Binding, and Efficacy in Rats

Published:2013-05 Issue:5 Volume:14 Page:692-705
ISSN:1526-2375
Container-title:Pain Medicine
language:en
Short-container-title:Pain Med

Author:

Smith Maree T.,Wyse Bruce D.,Edwards Stephen R.

Publisher

Oxford University Press (OUP)

Subject

Anesthesiology and Pain Medicine,Neurology (clinical),General Medicine

Link

http://academic.oup.com/painmedicine/article-pdf/14/5/692/5141584/14-5-692.pdf

Reference24 articles.

1. The evidence for pharmacological treatment of neuropathic pain

2. Uncovering New Pharmacological Targets to Treat Neuropathic Pain by Understanding How the Organism Reacts to Nerve Injury

3. The discovery and development of analgesics: new mechanisms, new modalities

4. Developmental expression patterns for angiotensin receptors in mouse skin and brain

5. Modulation of net outward current in cultured neurons by angiotensin II: involvement of AT1 and AT2 receptors

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential Regulation of Intracisternally Injected Angiotensin II-Induced Mechanical Allodynia and Thermal Hyperalgesia in Rats;Biomedicines;2023-12-12

2. Evolving views on the first two ligands of the angiotensin II type 2 receptor. From putative antagonists to potential agonists?;European Journal of Pharmacology;2023-12

3. Angiotensin II type 2 receptor signalling as a pain target: Bench, bedside and back-translation;Current Opinion in Pharmacology;2023-12

4. Neuropathic pain: From actual pharmacological treatments to new therapeutic horizons;Pharmacology & Therapeutics;2023-11

5. Investigational Drugs for the Treatment of Postherpetic Neuralgia: Systematic Review of Randomized Controlled Trials;International Journal of Molecular Sciences;2023-08-20